Loading...
Not a good buy right now for an impatient trader. WEC is extended/overbought (RSI_6 79.6) and trading just under near-term resistance (111.07) ahead of earnings (Feb 5 pre-market). While options positioning skews bullish and fundamentals look steady, the near-term technical setup and pattern-based forecast skew negative, making the current price a poor immediate entry.
Price: 110.67 (near R1 111.069; above pivot 109.423). Momentum is still positive but tiring: MACD histogram is >0 (0.393) and positively contracting, which often signals upside momentum is fading rather than accelerating. RSI_6 at ~79.6 indicates an overbought/extended condition (despite the provided label), increasing pullback risk for a near-term entry. Moving averages are converging, suggesting trend strength is not expanding. Key levels: support S1 107.777 (then S2 106.759); resistance R1 111.069 (then R2 112.087). Pattern-based projection provided is bearish-leaning (60% chance of -2.3% next day; -4.79% next week), aligning with the overbought/near-resistance setup.
Intellectia Proprietary Trading Signals

Latest quarter provided: 2025/Q3. Growth was solid: Revenue 2.104B (+12.91% YoY), Net Income 271.3M (+12.99% YoY), EPS 0.83 (+9.21% YoY). Profitability was slightly softer at the gross margin line (53.35%, -0.80% YoY), but overall earnings and top-line trends were positive heading into Q4 earnings.
Recent trend: broadly stable ratings (many Neutral/Equal Weight, a couple Overweight) but price targets have been cut across firms (RBC 131->127; Wells 124->117; BofA 122->116; UBS 119->115; JPM 121->113; Barclays adjustments including 110->105 then 105->110). Wall Street pros: high-quality utility profile and identifiable growth drivers (e.g., data-center load/capex opportunities) with consistent execution cited. Cons: valuation/peer-multiple sensitivity and a ‘back-end loaded’ outlook narrative, plus repeated target trims implying limited near-term upside from current levels.